Divergent reactivity of usnic acid and evaluation of its derivatives for antiproliferative activity against cancer cells.


Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 06 12 2022
revised: 04 01 2023
accepted: 06 01 2023
pubmed: 19 1 2023
medline: 1 2 2023
entrez: 18 1 2023
Statut: ppublish

Résumé

Natural products continue to be an inspiration for new drugs to treat debilitating diseases such as cancer. Usnic acid is a secondary metabolite isolated predominately from lichen species and has been shown to exhibit antiproliferative properties, however its application is limited by poor drug-like properties and low specificity. We report our work on investigating the reactivity of usnic acid for incorporating heterocyclic rings and the divergent reactivity that can be obtained by simply altering the reaction solvent and temperature. The synthesised derivatives were then tested against HeLa cancer cells for their antiproliferative properties. A number of promising compounds were obtained including 4, 5 and 9 that showed an IC

Identifiants

pubmed: 36652792
pii: S0968-0896(23)00005-6
doi: 10.1016/j.bmc.2023.117157
pii:
doi:

Substances chimiques

usnic acid 0W584PFJ77
Benzofurans 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

117157

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Gregory A Gunawan (GA)

Research School of Chemistry, Australian National University, 2600 Canberra, Australian Capital Territory, Australia.

Mariola Gimła (M)

University of Gdańsk, Faculty of Biology, Department of Medical Biology and Genetics, 80-308 Gdańsk, Poland.

Michael G Gardiner (MG)

Research School of Chemistry, Australian National University, 2600 Canberra, Australian Capital Territory, Australia.

Anna Herman-Antosiewicz (A)

University of Gdańsk, Faculty of Biology, Department of Medical Biology and Genetics, 80-308 Gdańsk, Poland.

Tristan A Reekie (TA)

Research School of Chemistry, Australian National University, 2600 Canberra, Australian Capital Territory, Australia; School of Science, University of New South Wales Canberra, 2600 Canberra, Australian Capital Territory, Australia. Electronic address: t.reekie@adfa.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH